Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice
Dendritic cell (DC)-based vaccines pulsed with high hydrostatic pressure (HHP)-inactivated tumor cells have recently been shown to be a promising tool for prostate cancer chemoimmunotherapy. In this study, DC-based vaccines, both pulsed and unpulsed, were as effective as docetaxel (DTX) in reducing...
Main Authors: | Romana Mikyskova, Marie Indrova, Ivan Stepanek, Ivan Kanchev, Jana Bieblova, Sarka Vosahlikova, Irena Moserova, Iva Truxova, Jitka Fucikova, Jirina Bartunkova, Radek Spisek, Radislav Sedlacek, Milan Reinis |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1362528 |
Similar Items
-
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications
by: Jitka Fucikova, et al.
Published: (2019-10-01) -
Neutropenic Enterocolitis in the Treatment of Solid Tumors: A Case Report and Review of the Literature
by: Sara Cherri, et al.
Published: (2020-04-01) -
Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting
by: Choi JS, et al.
Published: (2016-12-01) -
Effects of Docetaxel Combined with Icotinib on Serum Tumor Markers and Quality of Life of Patients with Advanced Non-Small Cell Lung Cancer
by: Huawei LIN, et al.
Published: (2020-10-01) -
Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer
by: Li S, et al.
Published: (2019-04-01)